• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders

    10/7/24 4:30:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email

    Notes that Purported Nomination of Director Candidates by a Riverstyx Principal Is Invalid and that the Nominations Will Not be Recognized

    RESEARCH TRIANGLE PARK, N.C., Oct. 7, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today commented on a letter sent to the Company's shareholders and released publicly by Riverstyx Capital Management, LLC ("Riverstyx"). The Company provided the following statement in response:

    (PRNewsfoto/Charles & Colvard, Ltd.)

    On August 27, Charles & Colvard received a purported notice (the "Notice") from Ben Franklin, a principal of Riverstyx Capital Management, indicating his intention to nominate three candidates to stand for election to Charles & Colvard's Board of Directors (the "Board") at the Company's upcoming Annual Meeting (the "Annual Meeting").

    Like most public companies, Charles & Colvard's Bylaws require a shareholder that wishes to nominate candidates for election to provide the Company with advance notice and relevant information regarding the shareholder and its candidates. The aim of such provisions, which numerous courts have recognized as valid, is to ensure that the Board and shareholders have adequate information with which to evaluate candidates and make an informed decision about the nomination and election of directors.

    The Notice failed to comply with the clear requirements of the Company's 2011 Amended and Restated Bylaws (the "Bylaws"), which are consistent with the Bylaws of the majority of public companies in relevant respects. Among many other deficiencies, the Notice omitted basic and critical information required by the Bylaws, such as:

      • The biographies and work histories of the candidates;
      • The ownership stakes of the candidates and of the nominating person (Mr. Franklin) and his affiliates and associates, which appear to include various entities that own the Company's stock that are not even mentioned in the Notice; and
      • The consent of each candidate to serve as a director.

    After a comprehensive review of the Notice and its deficiencies, and with input from its advisors, the Board today notified Mr. Franklin that the Notice is invalid. Mr. Franklin waited until the day before the last day of the nomination window to deliver the deficient Notice. Accordingly, the Company will not recognize Mr. Franklin's nominations. Any proxies submitted, or votes cast, for the election of Mr. Franklin's candidates will be disregarded.

    Charles & Colvard's Board is committed to acting in the best interests of all shareholders and has invited Mr. Franklin to share his perspectives on the Company's business and strategy directly with the Board. The Board and management team look forward to constructively engaging with Mr. Franklin.

    Charles & Colvard's Board will make a recommendation to shareholders with respect to the upcoming Annual Meeting and director elections in due course. Charles & Colvard shareholders are not required to take any action at this time.

    About Charles & Colvard, Ltd.

    Charles & Colvard, Ltd. (NASDAQ:CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, not Mined™ above ground gemstones and a dedication to 100% recycled precious metals. The Company's Forever One™ moissanite and Caydia® lab grown diamond brands provide exceptional quality, incredible value and a conscious approach to bridal, high fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit https://www.charlesandcolvard.com/.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.

    All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; risks related to our ongoing confidential arbitration and relationship with Wolfspeed, Inc.; our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; the execution of our business plans could significantly impact our liquidity; negative or inaccurate information on social media could adversely impact our brand and reputation; our failure to maintain compliance with The Nasdaq Stock Market's continued listing requirements, including filing our U.S. Securities and Exchange Commission ("SEC") reports on a timely basis, could result in the delisting of our common stock; and the other risks and uncertainties described in more detail in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the SEC that discuss other factors relevant to our business.

    Important Additional Information Regarding Proxy Solicitation 

    Charles & Colvard intends to file a proxy statement and WHITE proxy card with the SEC in connection with the solicitation of proxies for the Company's upcoming Annual Meeting. Charles & Colvard, its directors and certain of its executive officers will be participants in the solicitation of proxies from shareholders in respect of the Annual Meeting. Information regarding the names of Charles & Colvard's directors and executive officers and their respective interests in the Company's securities or otherwise is set forth in the Company's proxy statement for the 2024 Special Meeting of Shareholders, filed with the SEC on April 8, 2024 (the "Special Meeting Proxy Statement"), and the proxy statement for the 2023 Annual Meeting of Shareholders, filed with the SEC on October 27, 2023 (together with the Special Meeting Proxy Statement, the "Prior Proxy Statements"). To the extent holdings of such participants in Charles & Colvard's securities have changed since the amounts described in the Prior Proxy Statements, such changes have been reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC. Additional information can also be found in the Company's Annual Report on Form 10-K for the year ended June 30, 2023, filed with the SEC on October 12, 2023, and subsequent reports filed by the Company with the SEC. Details concerning the nominees of the Charles & Colvard Board of Directors for election at the upcoming Annual Meeting will be included in the proxy statement to be filed for the Annual Meeting. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SHAREHOLDERS OF CHARLES & COLVARD ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, INCLUDING THE COMPANY'S DEFINITIVE PROXY STATEMENT AND ANY AMENDMENTS AND SUPPLEMENTS THERETO ONCE AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. These documents, including the definitive proxy statement (and any amendments or supplements thereto) and other documents filed by Charles & Colvard with the SEC, are or will be available for no charge at the SEC's website at http://www.sec.gov and at Charles & Colvard's investor relations website at https://ir.charlesandcolvard.com/.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-ltd-comments-on-a-letter-from-riverstyx-capital-management-to-charles--colvard-shareholders-302269147.html

    SOURCE Charles & Colvard, Ltd.

    Get the next $CTHR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Charles & Colvard, Ltd. Announces Delisting from Nasdaq

      RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

      4/22/25 4:45:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

      RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For

      3/3/25 4:45:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard, Ltd. Receives Interim Award in Wolfspeed Arbitration

      RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on December 5, 2024, it received an interim award in its confidential arbitration with Wolfspeed, Inc.  Importantly, the award rejected Wolfspeed's claims to expectation damages of approximately $22.8 million, limiting the Company's damages to just $3.3 million representing approximately $1.3 million for inventory previously purchased and approximately $2.0 million of consigned inventory in the Company's possession, that will now be recorded on the Company's balance sheet as of June 30, 2024 - along with interest, arbitration and limite

      12/11/24 4:10:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/7/24 4:15:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 6:21:11 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 9:15:15 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

      SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      2/26/24 7:00:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

      SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      2/14/24 9:00:30 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

      SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

      11/20/23 4:15:12 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/7/24 4:15:57 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 6:21:11 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

      4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

      3/5/24 9:15:15 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    See more
    • CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

      Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

      5/2/24 4:07:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

      RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

      4/23/24 4:08:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

      Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

      2/13/24 4:07:00 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Roth Capital reiterated coverage on Charles & Colvard with a new price target

      Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

      9/3/21 8:46:46 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    See more
    • Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

      ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

      11/14/24 4:00:00 PM ET
      $CTHR
      $MLSS
      Consumer Specialties
      Consumer Discretionary
      Industrial Specialties
      Health Care
    • Charles & Colvard Joins Russell Microcap® Index

      RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

      6/28/21 9:16:00 AM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary

    $CTHR
    SEC Filings

    See more
    • SEC Form SD filed by Charles & Colvard Ltd

      SD - CHARLES & COLVARD LTD (0001015155) (Filer)

      6/2/25 5:24:13 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • SEC Form NT 10-Q filed by Charles & Colvard Ltd

      NT 10-Q - CHARLES & COLVARD LTD (0001015155) (Filer)

      5/16/25 5:06:09 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary
    • Charles & Colvard Ltd filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

      4/22/25 5:02:42 PM ET
      $CTHR
      Consumer Specialties
      Consumer Discretionary